Allinaire Therapeutics

With its acquisition of Ireland's Amryt Pharma set to complete shortly after Easter, Chiesi Farmaceutici S.p.A. can expect a healthy rise in revenues for 2023 having just posted a strong set of fi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, Flagship Hope Combined Ef

With $145m in new capital, Apollo Therapeutics LLC is looking to move to the next level by taking its 15-plus preclinical programs sourced from three UK universities into clinical development. As Ap

Since its inception in 2015, BridgeBio Pharma, Inc. has employed a hub-and-spoke business model similar to those used by Roivant Sciences Ltd. and Fortress Biotech Inc. , putting its expertise an